Lin Yi-Wen, Liu Meng-Chuan, Lu Ting-Jang, Ho Yun-Yang, Chen Ting-Wen, Yang Yao-Jong
Departments of Pediatrics, National Cheng Kung University Hospital; College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Departments of Pediatrics, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.
J Food Sci. 2025 Aug;90(8):e70484. doi: 10.1111/1750-3841.70484.
Human milk microbiota (HMM) and human milk oligosaccharides (HMOs) are crucial components of breast milk that influence infant health and development. This study provides long-term insights into the dynamic changes in HMM and HMOs and their interactions among Taiwanese lactating mothers. A cohort of 90 mothers with singleton, full-term infants contributed 319 breast milk samples across eight lactation stages over 52 weeks. HMOs were quantified using mass spectrometry, while milk microbiota composition was analyzed through 16S rRNA sequencing. Our findings reveal that HMO concentrations steadily declined from birth to 52 weeks postpartum. The most abundant HMO was 2'-fucosyllactose (2'-FL, 18.8%), followed by 3-fucosyllactose (3-FL, 16.5%). Notably, 2'-FL levels decreased over time, while 3-FL concentrations increased. Other HMOs exhibited a general downward trend throughout lactation. HMM composition also shifted dynamically, with significant variations in α-diversity and β-diversity across lactation stages. The predominant bacterial genera-Streptococcus, Pseudomonas, and Staphylococcus-showed distinct bimodal temporal patterns. Correlation analyses revealed that tetratose and sialylated HMOs were positively associated with Bacteroides abundance, while multiple HMOs negatively correlated with Streptococcus. These findings underscore the complex interactions between breast milk oligosaccharides and microbial communities, highlighting their potential implications for infant gut health. Further research is needed to explore the clinical significance of these transformations and their role in shaping the early-life microbiome. PRACTICAL APPLICATIONS: This study shows how breast milk changes over time, with certain sugars (HMOs) decreasing and others shifting, while beneficial bacteria also fluctuate. These changes may influence an infant's gut health and development. Understanding these patterns can help improve infant nutrition, guide breastfeeding recommendations, and support the design of better infant formulas or probiotics.
人乳微生物群(HMM)和人乳寡糖(HMOs)是母乳的关键组成部分,会影响婴儿的健康和发育。本研究对台湾哺乳期母亲的HMM和HMOs的动态变化及其相互作用提供了长期见解。一组90名单胎、足月儿母亲在52周内的八个泌乳阶段提供了319份母乳样本。使用质谱法定量分析HMOs,同时通过16S rRNA测序分析乳汁微生物群组成。我们的研究结果显示,HMO浓度从产后到52周稳步下降。含量最丰富的HMO是2'-岩藻糖基乳糖(2'-FL,18.8%),其次是3-岩藻糖基乳糖(3-FL,16.5%)。值得注意的是,2'-FL水平随时间下降,而3-FL浓度增加。在整个哺乳期,其他HMOs总体呈下降趋势。HMM组成也动态变化,在泌乳阶段α多样性和β多样性有显著差异。主要细菌属——链球菌属、假单胞菌属和葡萄球菌属——呈现出明显的双峰时间模式。相关性分析表明,四糖和唾液酸化HMOs与拟杆菌属丰度呈正相关,而多种HMOs与链球菌属呈负相关。这些发现强调了母乳寡糖与微生物群落之间的复杂相互作用,突出了它们对婴儿肠道健康的潜在影响。需要进一步研究来探索这些变化的临床意义及其在塑造早期微生物组中的作用。实际应用:本研究展示了母乳如何随时间变化,某些糖类(HMOs)减少而其他糖类发生变化,同时有益细菌也会波动。这些变化可能会影响婴儿的肠道健康和发育。了解这些模式有助于改善婴儿营养、指导母乳喂养建议,并支持设计更好的婴儿配方奶粉或益生菌。